Page 2 - Opgen News Today

Research analysts at StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the medical research company’s stock. OpGen Stock Performance OpGen stock opened at $0.39 on Wednesday. OpGen has a fifty-two week low of […]

Stock analysts at StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “sell” rating on the medical research company’s stock. OpGen Trading Down 2.3 % Shares of NASDAQ:OPGN opened at $0.42 on Tuesday. OpGen has a 12-month […]

StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Monday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Down 2.9 % NASDAQ:OPGN opened at $0.42 on Monday. The stock has a market cap of $4.16 million, a P/E ratio of […]

StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Monday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN stock opened at $0.42 on Monday. The firm’s 50 day moving average price is $0.49 and its 200-day […]

StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report released on Sunday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Price Performance Shares of NASDAQ:OPGN opened at $0.45 on Friday. OpGen has a 1-year low of $0.17 and a 1-year high of $3.84. The […]

OpGen (NASDAQ:OPGN – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations. Analyst Recommendations This is a summary of […]

StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN opened at $0.38 on Friday. OpGen has a 1 year low of $0.17 and a 1 year high […]

Sanders Morris Harris LLC boosted its holdings in Precigen, Inc. (NASDAQ:PGEN – Free Report) by 26.2% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 410,000 shares of the biotechnology company’s stock after purchasing an additional 85,000 shares during the quarter. Sanders Morris Harris LLC […]

Sanders Morris Harris LLC increased its stake in Precigen, Inc. (NASDAQ:PGEN – Free Report) by 26.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 410,000 shares of the biotechnology company’s stock after purchasing an additional 85,000 shares during the quarter. Sanders Morris Harris LLC […]

StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report released on Friday morning. The brokerage issued a sell rating on the medical research company’s stock. Separately, HC Wainwright lowered OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. Check Out Our Latest […]